Comments
Shares of GlaxoSmithKline Pharmaceuticals will remain active on Thursday as the company is announcing its financial performance. Analysts expect muted growth as sales and profit margins came under pressure during the January-March quarter owing to the new drug policy. The company, which has lost the power to charge a premium on its drugs under the new pricing policy, is also facing supply chain-related issues with dealers on sales commissions.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.